GeneDx Holdings Corp. (WGS) Financials
WGS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 506.3 million | 252.2 million |
| Dec. 31, 2025 | 570.2 million | 262.0 million |
| Sept. 30, 2025 | 493.9 million | 201.6 million |
| June 30, 2025 | 463.9 million | 186.7 million |
WGS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -38.9 million | 9.0 million |
| Dec. 31, 2025 | -7.4 million | 9.8 million |
| Sept. 30, 2025 | 9.6 million | 10.6 million |
| June 30, 2025 | 8.1 million | 7.8 million |
WGS Net Income
No data available :(
WGS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 170.7 million | 96.7 million | 71.5 million |
| Dec. 31, 2025 | 171.3 million | 87.0 million | 56.0 million |
| Sept. 30, 2025 | 155.1 million | 51.6 million | 61.6 million |
| June 30, 2025 | 134.6 million | 51.7 million | 62.7 million |
WGS Shares Outstanding
WGS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 6.5 million | 19.8 million | 74.6 million | - |
| Dec. 31, 2025 | 4.3 million | 24.0 million | 74.4 million | 27.1 million |
| Sept. 30, 2025 | 6.2 million | 19.8 million | 67.9 million | 23.5 million |
| June 30, 2025 | 2.4 million | 14.9 million | 46.4 million | 19.4 million |
WGS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 102.3 million | 34.0 million |
| Dec. 31, 2025 | 121.0 million | 42.1 million |
| Sept. 30, 2025 | 116.7 million | 32.2 million |
| June 30, 2025 | 102.7 million | 31.8 million |
WGS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
WGS
Price: $56.27
52 week price:
Earnings Per Share: -2.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Market Capitalization: 1.6 billion